An investigation by the I-Team revealed that nonprofit hospitals in Massachusetts aren't helping patients entitled to ...

Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in ...

Details of Blue Shield-assigned member account numbers, claim service dates and service providers, patient names, and patients’ financial responsibility were also shared. Per a legally required ...

RIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. F ...

Following a pre-specified interim analysis, an independent Data Safety Monitoring Board (DSMB) recommended the pivotal Phase 3 trial (DR ...

Additional information regarding these results and other relevant information is included in the notes to the financial statements in “Item 18. Financial Statements”, which are included in InflaRx’s ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

Many investors have never heard of Eurofins Scientific, yet this French-based global leader in testing is woven into the ...

patient financial responsibility; and “Find a Doctor” search criteria and results (such as location, plan name and type, provider name and type). There was no disclosure of other types of ...